Genentech Shows Off Positive Results From Phase III HEMLIBRA, TECENTRIQ Studies Post author:Sam Post published:November 19, 2017 Post category:BioPharma Data will be submitted to health authorities globally, including the FDA and EMA. Source: BioSpace You Might Also Like Backed by Google, Cambridge's Spero Nabs $51.7 Million Series C March 7, 2017 Merck Plots 950-Job R&D Hub in London November 26, 2017 Xenex Locks in $38 Million in Funding February 23, 2017
